Browse Category

Financial Results News 13 November 2025 - 25 November 2025

Amer Sports (AS) Jumps After Q3 2025 Earnings Beat and Raised Outlook as Salomon & Arc’teryx Power 30% Sales Surge

Amer Sports (AS) Jumps After Q3 2025 Earnings Beat and Raised Outlook as Salomon & Arc’teryx Power 30% Sales Surge

Amer Sports, the Finnish parent of premium outdoor and sports brands like Arc’teryx, Salomon and Wilson, delivered a blockbuster third quarter on Tuesday, beating Wall Street expectations, raising full‑year 2025 guidance for the second time this year and sending its
Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial Corp. (NYSE: SNV) is back in the spotlight this week as investors digest a stronger‑than‑expected third quarter, a higher price target from Barclays, and fresh 13F filings showing new institutional money flowing into the regional bank. As of
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Stock on November 15, 2025: Pricing Deal, Oral‑Obesity Pill Timeline, Q3 Beat Put Shares Near $1T — Outlook & Risks

Updated: November 15, 2025 Key takeaways Where LLY stands today (Nov. 15, 2025) As of 00:40 UTC on Nov. 15, LLY is ~$1,025 (day range $1,003–$1,033). The 52‑week range is roughly $624–$1,034, and third‑party dashboards peg market cap in the
Milestone Scientific (MLSS) Soars on Q3 2025 Earnings, Cost Cuts and Board Shake-Up – Latest for 14 November 2025

Milestone Scientific (MLSS) Soars on Q3 2025 Earnings, Cost Cuts and Board Shake-Up – Latest for 14 November 2025

Milestone Scientific Inc. (NYSE American: MLSS) is back on traders’ radar today after a sharp after‑hours spike, strong pre‑market performance and fresh Q3 2025 numbers that show progress on costs but lingering listing‑compliance and funding risks. Key headlines on Milestone
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

CYPH Debuts: Cypherpunk Technologies (ex‑Leap Therapeutics) starts trading, files $200M ATM, posts Q3 results and details $50M Zcash treasury — 13 Nov 2025

Published: November 13, 2025 Cypherpunk Technologies Inc. — the newly renamed Leap Therapeutics — began trading on the Nasdaq this morning under the ticker CYPH, marking the company’s formal pivot from oncology biotech to a “digital‑asset treasury” strategy centered on
Tata Capital’s ₹15,500-Crore IPO Rocks 2025 Markets – Should You Bet on India’s Biggest Listing?

Tata Motors Commercial Vehicles (TMCV) Share Price Today, 13 November 2025: Profit‑Taking, Q2 Buzz and What It Means for Investors

Tata Motors’ newly listed commercial vehicles arm is having a busy second day on the bourses. On Thursday, 13 November 2025, Tata Motors Ltd (commercial vehicles business, ticker: TMCV) traded lower as investors booked profits ahead of the company’s first
1 2 3
Go toTop